Afuco™ Anti-Human PTK7 ADCC Recombinant Antibody, ADCC Enhanced (CAT#: AFC-692CL)

Anti-PTK7 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies target protein tyrosine kinase 7 (PTK7). They can use in preventing, treating or ameliorating hyperproliferative disorders and any expansion, recurrence, relapse or metastasis.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Host Species
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Related Disease
  • Cancer

Product Property

  • Purity
  • >95%, by SDS-PAGE, under reducing conditions
  • Storage
  • Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • PTK7; protein tyrosine kinase 7 (inactive); CCK4; CCK-4; inactive tyrosine-protein kinase 7; colon carcinoma kinase 4; PTK7 protein tyrosine kinase 7; tyrosine-protein kinase-like 7; pseudo tyrosine kinase receptor 7

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "PTK7"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products ScFv Antibody Products Fab Antibody Products

Customer Reviews and Q&As

Customer Review Q&As

Submit a review or a question


Great for Cancer Research
The Afuco™ Anti-PTK7 ADCC antibody has been a groundbreaking addition to my research on breast cancer. Its enhanced ADCC capability provides clear results, particularly when assessing PTK7 expression in malignant cells. This specificity and potency accelerate our understanding of PTK7's role in cancer progression.

Enhances Immune Assay Outcomes
The increased ADCC activity of this antibody has significantly boosted the outcomes of our immune assays. The enhanced recruitment of effector cells has provided new insights into PTK7-associated immune interactions, opening doors to further discoveries in immune-oncology.

Perfect for Collaborative Projects
We've used this antibody collaboratively across institutions, and its performance remains consistent irrespective of differing lab environments. This consistency facilitates comparative studies and multi-center research initiatives.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare